Drake & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Drake & Associates's MDT Position: Q3 2026 in Review
Drake & Associates reduced its Medtronic (MDT) stake by 14% in Q3 2026, selling an estimated $93.6K and leaving 6,395 shares worth $552K. The position accounts for 0.09% of the portfolio, ranked #71.
Drake & Associates first reported a position in MDT in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.52M in Q3 2025. 2,202 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Drake & Associates held 6,395 shares of Medtronic worth $552K as of Q3 2026.
- Drake & Associates sold 1,062 Medtronic shares in Q3 2026, an estimated $93.6K.
- Medtronic made up 0.09% of Drake & Associates's portfolio in Q3 2026, its #71 holding.
- Drake & Associates first reported a position in Medtronic in Q3 2025 and has held it in 5 quarters since.
- Drake & Associates's Medtronic position peaked at $2.52M in Q3 2025.
- 2,202 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.